Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fähndrich

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 8, 2011
[Chronic obstructive pulmonary disease: pathophysiology, diagnosis, and therapy]S Fähndrich, C Guttmann, R Bals
Pneumologie (Stuttgart, Germany)|June 4, 2020
[Alpha-1 Antitrypsin Deficiency (AATD) - D-A-CH-Expert Statement]T Greulich, S Fähndrich, C Clarenbach, et al.
Respiratory Medicine|June 17, 2019
Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohortF C Trudzinski, K Kahnert, C F Vogelmeier, et al.
Scientific Reports|July 1, 2020
Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONETF C Trudzinski, R A Jörres, P Alter, et al.
Respiratory Research|January 24, 2024
Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONETS Fähndrich, C Herr, S Teuteberg, et al.
Respiratory Research|May 15, 2024
Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohortN Frantzi, X P Nguyen, C Herr, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|September 8, 2011
[Chronic obstructive pulmonary disease: pathophysiology, diagnosis, and therapy]S Fähndrich, C Guttmann, R Bals
Pneumologie (Stuttgart, Germany)|June 4, 2020
[Alpha-1 Antitrypsin Deficiency (AATD) - D-A-CH-Expert Statement]T Greulich, S Fähndrich, C Clarenbach, et al.
Respiratory Medicine|June 17, 2019
Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohortF C Trudzinski, K Kahnert, C F Vogelmeier, et al.
Scientific Reports|July 1, 2020
Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONETF C Trudzinski, R A Jörres, P Alter, et al.
Respiratory Research|January 24, 2024
Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONETS Fähndrich, C Herr, S Teuteberg, et al.
Respiratory Research|May 15, 2024
Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohortN Frantzi, X P Nguyen, C Herr, et al.
Pageof 1